Page last updated: 2024-10-26

valproic acid and B-Cell Leukemia

valproic acid has been researched along with B-Cell Leukemia in 1 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stieglmaier, J1
Bremer, E1
Kellner, C1
Liebig, TM1
ten Cate, B1
Peipp, M1
Schulze-Koops, H1
Pfeiffer, M1
Bühring, HJ1
Greil, J1
Oduncu, F1
Emmerich, B1
Fey, GH1
Helfrich, W1

Other Studies

1 other study available for valproic acid and B-Cell Leukemia

ArticleYear
Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion protein.
    Cancer immunology, immunotherapy : CII, 2008, Volume: 57, Issue:2

    Topics: Animals; Antigens, CD19; Antineoplastic Agents; Apoptosis; Cyclosporine; Drug Synergism; Female; Flo

2008